Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

AB Science S.A (PA: AB)

 
AB Technical Analysis
5
As on 22nd Nov 2024 AB STOCK Price closed @ 0.80 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.93 & Strong Sell for SHORT-TERM with Stoploss of 3.64 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ABSTOCK Price

Open 0.79 Change Price %
High 0.80 1 Day 0.01 1.27
Low 0.79 1 Week -0.13 -13.98
Close 0.80 1 Month -0.17 -17.53
Volume 76143 1 Year -3.40 -80.95
52 Week High 4.55 | 52 Week Low 0.82
 
PA France Most Active Stocks
ALNEV 0.00 %
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ACA 13.05 -1.66%
ATO 0.16 0.00%
ALDRV 0.00 %
ORA 10.02 1.62%
CGG 0.69 -2.82%
BNP 56.92 -2.23%
ENGI 15.39 -0.52%
 
PA France Top Gainers Stocks
MLAAH 0.02 100.00%
GNRO 0.08 33.33%
ALSAF 0.11 22.22%
ALKKO 0.11 22.22%
FINM 0.11 10.00%
FINM 0.11 10.00%
2MX 7.46 8.43%
MLIML 0.39 8.33%
ATA 0.13 8.33%
ATA 0.13 8.33%
 
PA France Top Losers Stocks
ALIMO 0.19 -40.62%
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
MLNMA 0.08 -20.00%
ALTBG 0.29 -14.71%
ALSAS 5.15 -12.71%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
ALCOI 3.23 -9.78%
 
 
AB
Daily Charts		 AB
Intraday Charts		 Whats New @
Bazaartrend		 AB
Free Analysis
 
AB Important Levels Intraday
RESISTANCE0.82
RESISTANCE0.81
RESISTANCE0.81
RESISTANCE0.81
SUPPORT0.79
SUPPORT0.79
SUPPORT0.79
SUPPORT0.78
 
AB Forecast November 2024
Share
4th UP Forecast3.67
3rd UP Forecast2.75
2nd UP Forecast2.18
1st UP Forecast1.61
1st DOWN Forecast-0.01
2nd DOWN Forecast-0.58
3rd DOWN Forecast-1.15
4th DOWN Forecast-2.07
 
AB Weekly Forecast
4th UP Forecast1.44
3rd UP Forecast1.23
2nd UP Forecast1.11
1st UP Forecast0.98
1st DOWN Forecast0.62
2nd DOWN Forecast0.49
3rd DOWN Forecast0.37
4th DOWN Forecast0.16
 
AB Forecast2024
4th UP Forecast7.87
3rd UP Forecast5.6
2nd UP Forecast4.2
1st UP Forecast2.8
1st DOWN Forecast-1.2
2nd DOWN Forecast-2.6
3rd DOWN Forecast-4
4th DOWN Forecast-6.27
 
 
AB Other Details
Segment EQ
Market Capital 616233280.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
AB Address
AB
 
AB Latest News
 
Your Comments and Response on AB Science S.A
 
AB Business Profile
AB Science S.A., a clinical-stage pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases. The company is also developing AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase II clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was founded in 2001 and is headquartered in Paris, France. Address: 3, Avenue George V, Paris, France, 75008
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service